1-8 of 8
Anuradha Illendula
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nanoliposomal C6-Ceramide Exhibits Synergistic Anti-Cancer Activity with a Small Molecule Agonist of PP2A in Chronic Lymphocytic Leukemia

Kallesh D. Jayappa, Luke R. Vass, Caroline Farrington, Anuradha Illendula, Susan Walker, Michael E. Williams, Craig A. Portell, Todd Fox, Goutham Narla, Mark Kester
Journal: Blood
Blood (2022) 140 (Supplement 1): 7816–7817.
https://doi.org/10.1182/blood-2022-168086
Published: 2022
Journal Articles

The Novel Nano-Formulation of the HDAC Inhibitor, Romidepsin, for the Treatment of Relapsed, Refractory Peripheral T-Cell Lymphoma

Ipsita Pal, Anuradha Illendula, John Sanil Manavalan, Todd P Fox, Owen A. O'Connor, Thomas P. Loughran, Jr., Mark Kester, David J Feith, Enrica Marchi
Journal: Blood
Blood (2022) 140 (Supplement 1): 8848–8849.
https://doi.org/10.1182/blood-2022-167628
Published: 2022
Journal Articles

RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1

Christopher P. Mill, Warren Fiskus, Courtney D. DiNardo, Yimin Qian, Kanak Raina, Kimal Rajapakshe, Dimuthu Perera, Cristian Coarfa, Tapan M. Kadia, Joseph D. Khoury, Dyana T. Saenz, David N. Saenz, Anuradha Illendula, Koichi Takahashi, Steven M. Kornblau, Michael R. Green, Andrew P. Futreal, John H. Bushweller, Craig M. Crews, Kapil N. Bhalla
Journal: Blood
Blood (2019) 134 (1): 59–73.
https://doi.org/10.1182/blood.2018893982
Published: 2019
Includes: Supplemental data
Journal Articles

CBFβ-SMMHC Inhibition Disrupts Enhancer Chromatin Dynamics and Represses MYC Transcriptional Program in Inv(16) Leukemia

John Anto Pulikkan, PhD, Mahesh Hegde, Houda Belaghzal, Anuradha Illendula, Jun Yu, Hafiz Ahmed, Kelsey O'Hagen, Jianhong Ou, Carsten Müller-Tidow, Scot A. Wolfe, Julie Zhu, Job Dekker, John H. Bushweller, Lucio H. Castilla
Journal: Blood
Blood (2017) 130 (Supplement 1): 784.
https://doi.org/10.1182/blood.V130.Suppl_1.784.784
Published: 2017
Journal Articles

RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia

AHyun Choi, Anuradha Illendula, John A. Pulikkan, Justine E. Roderick, Jessica Tesell, Jun Yu, Nicole Hermance, Lihua Julie Zhu, Lucio H. Castilla, John H. Bushweller, Michelle A. Kelliher
Journal: Blood
Blood (2017) 130 (15): 1722–1733.
https://doi.org/10.1182/blood-2017-03-775536
Published: 2017
Includes: Supplemental data
Journal Articles

Selective Inhibition of the Leukemia Fusion Protein CBFβ-SMMHC By Small Molecule AI-10-49 in the Treatment of Inv(16) AML

John Anto Pulikkan, PhD, Anuradha Illendula, PhD, Jolanta Grembecka, Liting Xue, Roger Rajewski, Monica L. Guzman, PhD, John H. Bushweller, PhD, Lucio H. Castilla, PhD
Journal: Blood
Blood (2014) 124 (21): 390.
https://doi.org/10.1182/blood.V124.21.390.390
Published: 2014
Journal Articles

A Small Molecule Inhibitor of the CBFβ-SMMHC/RUNX Interaction Attenuates Inv(16) Leukemia in Vivo

John H. Bushweller, PhD, Anuradha Illendula, Ph.D., John Anto Pulikkan, Jolanta Grembecka, PhD, Paul Bradley, Yunpeng Zhou, Ph.D., Liting Xue, Yan Gao, Lucio H. Castilla, PhD
Journal: Blood
Blood (2012) 120 (21): 286.
https://doi.org/10.1182/blood.V120.21.286.286
Published: 2012
Journal Articles

Development of Small Molecule Inhibitors of the AML1-ETO and CBFβ-SMMHC Oncoproteins.

Jolanta E. Grembecka, PhD, Kristin Graf, Yali Kong, PhD, Michael Douvas, MD, Tomasz Cierpicki, PhD, Anuradha Illendula, PhD, Gwen Baber, Izabela Bielnicka, Liya Roudaia, Nancy A. Speck, PhD, Milton L. Brown, PhD, MD, John H. Bushweller, PhD
Journal: Blood
Blood (2007) 110 (11): 1591.
https://doi.org/10.1182/blood.V110.11.1591.1591
Published: 2007